Efavirenz (Sustiva): oral liquid expanded access program for children and adolescents ages 3-16.
A liquid form of efavirenz, still classified as experimental, will be made widely available through an expanded-access study for children who cannot easily take the capsules.
D000293:Adolescent; D000480:Alkynes; D048588:Benzoxazines; D002648:Child; D002675:Child, Preschool; D003521:Cyclopropanes; D017277:Drug Approval; D006801:Humans; D010078:Oxazines / Q000600:supply & distribution / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000600:supply & distribution / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz